Halozyme Therapeutics - ENHANZE Licensing Revenues Boost Results Significantly!
Reading Time: 1 minute
Business Drivers: The US biotech company Halozyme Therapeutics (HALO) specializes in products related to proprietary enzyme technology. The ENHANZE technology developed by Halozyme allows for the subcutaneous administration of biological and medicinal substances, which offers significant advantages compared to traditional intramuscular or intravenous delivery of drugs and medications. Among its clientele are renowned pharmaceutical companies such as Roche, Pfizer, and Johnson & Johnson. On August 5th, Halozyme surprised with very strong...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
